Summary
Telomerase activity, associated with cellular immortalization and tumorigenesis, is suppressed during terminal differentiation of HL-60 promyelocytic leukaemic cells. However, it is poorly understood how telomerase activity is regulated in differentiated HL-60 cells. In the present study, we demonstrate that the down-regulation of telomerase reverse transcriptase (hTERT) expression, the catalytic subunit, occurs prior to the suppression of telomerase activity in differentiated HL-60 cells. In contrast, the expression of telomerase RNA template (hTR) and telomerase associated protein (TP1) is not reduced. This down-regulation of hTERT expression is achieved through inhibition of gene transcription, in which process new protein synthesis is required. Moreover, the rapid down-regulation of hTERT expression followed by the inhibition of telomerase activity is a specific component of the differentiation programme and not simply a consequence of cell cycle arrest. Serum-deprivation of HL-60 cells causes cell cycle arrest without differentiation and this does not result in a significant reduction in hTERT mRNA levels within the first 24 h. Our findings suggest that hTERT expression is stringently controlled at transcriptional level in HL-60 cells. The downregulation of hTERT expression in the HL-60 cell differentiation model may represent a general regulatory mechanism through which telomerase becomes repressed during development and differentiation of human somatic cells.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Albanell, J., Han, W., Mellado, B., Gunawardane, R., Scher, H. & Dmitrovsky, E. (1996). Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res 56: 1503–1508.
Beattie, T. L., Zhou, W., Robinson, M. O. & Harrington, L. (1998). Reconstitution of telomerase activity in vitro. Curr Biol 8: 177–180.
Bestilny, L., Brown, C., Miura, Y., Robertson, L. & Riabowol, K. (1996). Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res 56: 3796–3802.
Bodnar, A., Ouellette, M., Frolkis, M., Holt, S., Chiu, C., Morin, G., Harley, C., Shay, J., Lichtsteiner, S. & Wright, W. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349–352.
Feng, L., Funk, W., Wang, S-S, Weinrich, S., Avillion, A., Chiu, C., Adams, R., Chang, E., Allsopp, R., Yu, J., Le, S., West, M., Harley, C., Andrews, W., Greider, C. & Villeponteau, B. (1995). The RNA component of human telomerase. Science 269: 1236–1241.
Greider, C. W. (1998). Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 95: 90–92.
Harley, C. B., Kim, N. W., Prowse, K. R., Weinreich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M., Greider, C. W., Piatyszek, M. A., Weight, W. E. & Shay, J. W. (1994). Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp Quant Biol 59: 307–315.
Harrington, L., Mcphail, T., Mar, V., Zhou, W., Oulton, R., Bass, M., Arruda, I. & Robinson, M. (1997). A mammalian telomerase-associated protein. Science 275: 973–977.
Herzog, C., Tsokos, M., Bates, S. & Fojo, A. (1993). Increased mdr-1/p-glycoprotein expression after treatment of human colon carcinoma cells with p-glycoprotein antagonists. J Biol Chem 268: 2946–2952.
Holt, S. E., Wright, W. E. & Shay, J. W. (1996). Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 16: 2932–2939.
Kilian, A., Bowtell, D. D. L., Abud, H. E., Hime, G. R., Venter, D. J., Keese, P. K., Duncan, E. L., Reddel, R. R. & Jefferson, R. A. (1997). Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 12: 2011–2019.
Kim, N., Ma, M. P., Prowse, K., Harley, C., West, M., Ho, P., Coviello, G., Wright, W., Weinrich, S. & Shay, J. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011–2015.
Matikainen, S., Ronni, T., Hurme, M. & Pine, R., Julkunen (1996). Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 88: 114–123.
Meyerson, M., Counter, C., Eaton, E., Ellisen, L., Steiner, P., Caddle, S., Ziaugra, L., Beijersbergen, R., Davidoff, M., Liu, Q., Bacchetti, S., Haber, D. & Weinberg, R. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785–795.
Nakamura, T., Morin, G., Chapman, K., Weinrich, S., Andrews, W., Lingner, J., Harley, C. & Cech, T. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955–959.
Reichman, T., Albanell, J., Wang, X., Moore, M. & Studzinski, G. (1997). Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J Cell Biochem 67: 13–23.
Xu, D., Gruber, A., Peterson, C. & Pisa, P. (1996). Suppression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia 10: 1354–1357.
Xu, D., Gruber, A., Peterson, C. & Pisa, P. (1998). Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br J Haematol 102: 1365–1373.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Xu, D., Gruber, A., Björkholm, M. et al. Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br J Cancer 80, 1156–1161 (1999). https://doi.org/10.1038/sj.bjc.6690480
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690480
Keywords
This article is cited by
-
Diverse regulatory manners of human telomerase reverse transcriptase
Cell Communication and Signaling (2019)
-
Nanosecond pulsed electric fields induce extracellular release of chromosomal DNA and histone citrullination in neutrophil-differentiated HL-60 cells
Scientific Reports (2019)
-
Reactivation of telomerase in cancer
Cellular and Molecular Life Sciences (2016)
-
Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells
Cancer Chemotherapy and Pharmacology (2006)
-
Effects of all-trans retinoic acid on hTERT gene expression and telomerase activity of HL-60 cells
The Chinese-German Journal of Clinical Oncology (2003)